Lila says three scientists designed a CAR-T candidate in months

The preclinical result offers a test of Lila's autonomous-science pitch, though the company has not published the underlying data.

By · Published

Primary source: X

Why it matters

Lila's claim moves autonomous science from workflow demos toward a commercial-therapy benchmark, but preclinical data and human results remain the tests that count.

Lila says three scientists designed a CAR-T candidate in months — The preclinical result offers a test of Lila's autonomous-science pitch, though the company has not published the underlying data.

Jing (@JinghanOng) said on August 28th that three Lila Sciences scientists designed a new CAR-T cancer therapy in a matter of months, then produced preclinical results that beat what Jing described as a leading therapy already used in patients.…

Reader comments

Conversation for this story loads after sign-in.